Strs Ohio Has $1.94 Million Stake in Hologic, Inc. (HOLX)

Strs Ohio raised its position in Hologic, Inc. (NASDAQ:HOLX) by 49.0% during the second quarter, Holdings Channel reports. The fund owned 42,706 shares of the medical equipment provider’s stock after buying an additional 14,049 shares during the period. Strs Ohio’s holdings in Hologic were worth $1,937,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Teachers Advisors LLC boosted its position in Hologic by 28.8% in the fourth quarter. Teachers Advisors LLC now owns 643,547 shares of the medical equipment provider’s stock worth $25,819,000 after buying an additional 143,960 shares during the last quarter. Chevy Chase Trust Holdings Inc. boosted its position in Hologic by 3.6% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 240,769 shares of the medical equipment provider’s stock worth $10,245,000 after buying an additional 8,289 shares during the last quarter. Gulf International Bank UK Ltd boosted its position in Hologic by 1.5% in the first quarter. Gulf International Bank UK Ltd now owns 74,164 shares of the medical equipment provider’s stock worth $3,155,000 after buying an additional 1,100 shares during the last quarter. National Pension Service boosted its position in Hologic by 55,168.1% in the first quarter. National Pension Service now owns 244,285 shares of the medical equipment provider’s stock worth $10,433,000 after buying an additional 243,843 shares during the last quarter. Finally, Fox Run Management L.L.C. boosted its position in Hologic by 117.2% in the first quarter. Fox Run Management L.L.C. now owns 12,600 shares of the medical equipment provider’s stock worth $536,000 after buying an additional 6,800 shares during the last quarter. Institutional investors own 94.46% of the company’s stock.

Hologic, Inc. (NASDAQ HOLX) opened at 37.39 on Friday. Hologic, Inc. has a 12 month low of $35.15 and a 12 month high of $46.80. The company’s 50 day moving average is $43.97 and its 200 day moving average is $42.90. The stock has a market cap of $10.49 billion, a PE ratio of 13.93 and a beta of 0.90.

Hologic (NASDAQ:HOLX) last posted its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.50 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.49 by $0.01. The company had revenue of $806.10 million for the quarter, compared to the consensus estimate of $799.70 million. Hologic had a net margin of 25.65% and a return on equity of 23.18%. The firm’s revenue was up 12.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.51 EPS. On average, analysts anticipate that Hologic, Inc. will post $2.01 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Strs Ohio Has $1.94 Million Stake in Hologic, Inc. (HOLX)” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/2801492/strs-ohio-has-1-94-million-stake-in-hologic-inc-holx.html.

A number of equities analysts have issued reports on HOLX shares. Zacks Investment Research cut shares of Hologic from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. Royal Bank Of Canada decreased their price objective on shares of Hologic from $50.00 to $45.00 and set a “sector perform” rating on the stock in a research report on Thursday, August 3rd. Deutsche Bank AG decreased their price objective on shares of Hologic from $51.00 to $49.00 and set a “buy” rating on the stock in a research report on Thursday, August 3rd. Stifel Nicolaus boosted their price objective on shares of Hologic from $45.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, May 11th. Finally, Piper Jaffray Companies restated a “buy” rating and issued a $51.00 price objective on shares of Hologic in a research report on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the stock. Hologic has an average rating of “Buy” and an average target price of $48.64.

In related news, Director Elaine Ullian sold 6,902 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $40.12, for a total value of $276,908.24. Following the transaction, the director now owns 23,810 shares of the company’s stock, valued at approximately $955,257.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Lawrence M. Levy sold 9,076 shares of the firm’s stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $42.80, for a total transaction of $388,452.80. Following the completion of the transaction, the director now directly owns 43,165 shares in the company, valued at approximately $1,847,462. The disclosure for this sale can be found here. Insiders sold a total of 60,627 shares of company stock worth $2,632,911 in the last ninety days. 0.79% of the stock is currently owned by insiders.

About Hologic

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.